Of 970 measles cases studied, 574 were eligible to receive the vaccine but chose not to.
Whole cell pertussis vaccines are more effective than newer, acellular versions.
Among kids at several UK general practices, 20% had evidence of recent pertussis infection.
Of patients with a vaccine history, 9% have never been vaccinated.
Clinicians who recognize various types of pediatric coughs will be better able to identify serious underlying conditions in the young patient.
Opt-in and standing orders increase postpartum pertussis vaccination rates from 0% to 69%.
Spatial clustering of nonmedical vaccine exemptions in California linked with clusters of pertussis cases.
Children who missed three doses of DTaP were almost 19 times more likely to develop pertussis than those who were appropriately vaccinated.
Pertussis cases expected to surpass rates in the 1950s in ongoing Texas whooping cough epidemic.
New York state vaccine exemption rates nearly doubled from 2000 to 2011, and counties with higher proportions of vaccine exemptions reported greater pertussis incidence.
Analyses reveal 2011-2012 U.S. pertussis isolates were negative for pertactin, a virulence factor that is a component of the current accellular vaccine.
Children who were vaccinated with both whole cell (DTwP) and acellular (DTaP) forms of pertussis vaccine have higher rates of disease, if their first dose was DTaP.
During the first six months of 2012, Washington state reported 2,520 pertussis cases -- a 1,300% increase from the first six months of 2011, the CDC reports.
Most hospitalizations and all deaths in the 2010 California pertussis outbreak occurred in infants aged younger than 3 months.
With decreased immunization rates, whooping cough seems to be making a comeback, showing its distinctive sound particularly on the Pacific coast.
Only 5.9% of eligible candidates receive the recommended pertussis booster vaccine, and the disease remains one of the leading causes of vaccine-preventable deaths worldwide.